【2024 新作】 Discovery α of treatment the for scaffold novel a with inhibitor inflammasome NLRP3 brain-penetrable and active orally potent, A (ASP0965): 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol of 精神医学
【2024 新作】 Discovery α of treatment the for scaffold novel a with inhibitor inflammasome NLRP3 brain-penetrable and active orally potent, A (ASP0965): 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol of 精神医学
Discovery of 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol (ASP0965): A potent, orally active and brain-penetrable NLRP3 inflammasome inhibitor with a novel scaffold for the treatment of α ,Discovery of 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol (ASP0965): A potent, orally active and brain-penetrable NLRP3 inflammasome inhibitor with a novel scaffold for the treatment of α ,CN114761019A - 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法- Google Patents,星形胶质细胞衰老- Genspark,中山七院血液内科团队在国际顶级药学期刊Journal of Controlled Release上发表关于原发中枢神经系统淋巴瘤治疗的研究成果| 中山大学附属第七医院 精神科治療ハンドブック 大原 健士郎 本日発送 ⭐️恋みのり&ゆめのか⭐️ 正規品&B品、訳あり 800g いちご ③